Daily Derm Times: February 18, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Tackling Unmet Needs in Dermatology With Rezpegaldesleukin

Jonathan Zalevsky, PhD, discusses the unmet needs in atopic dermatitis treatment, the potential of Rezpeg, and the importance of novel therapies.

FDA Accepts sBLA for Dupilumab as Potential BP Treatment

Patients treated with dupilumab showed significant reductions in disease severity, itch, and corticosteroid use.

Higher Psoriatic Arthritis Disease Burden Found Among Hispanic, Non-White Patients

Hispanic and non-White patients with psoriatic arthritis (PsA) had higher tender joint counts and greater disease severity, highlighting racial and ethnic disparities in PsA disease burden and treatment outcomes.

How Path AI’s PathAssist Derm Tool Aims to Enhance Skin Cancer Diagnosis and Workflow Efficiency

Although the tool is currently designed for research use only, CEO Andy Beck, MD, PhD, is excited about its future in clinical dermatopathology.

Aesthetic Treatments: More Than Just Enhancements, A Path to Empowerment

Merz Aesthetics' global study reveals that aesthetic treatments boost self-confidence, social well-being, and self-perception beyond physical appearance.

SLIDESHOW: Previewing Masterclasses in Dermatology 2025

Click through our slideshow to see a glimpse of what the 2025 Masterclasses in Dermatology conference has to offer.